Emerce, Esra <br/><br/>
Determination of the impurities in drug products containing montelukast and in silico/in vitro genotoxicological assessments of sulfoxide impurity.  [electronic resource] 

 -  Toxicology letters  Oct 2015 
 - 90-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-3169 
<br/><br/><label>Standard No.: </label>10.1016/j.toxlet.2015.07.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetates--analysis<br/>Adult<br/>Animals<br/>Anti-Asthmatic Agents--analysis<br/>Cells, Cultured<br/>Chemistry, Pharmaceutical<br/>Chromatography, High Pressure Liquid<br/>Chromatography, Reverse-Phase<br/>Chromosome Aberrations--chemically induced<br/>Computer Simulation<br/>Cyclopropanes<br/>Dose-Response Relationship, Drug<br/>Drug Contamination<br/>Female<br/>Gene Expression Regulation, Bacterial--drug effects<br/>Humans<br/>Leukotriene Antagonists--analysis<br/>Lymphocytes--drug effects<br/>Male<br/>Mitosis--drug effects<br/>Mitotic Index<br/>Mutagenicity Tests<br/>Mutation<br/>Quinolines--analysis<br/>Rats, Sprague-Dawley<br/>Risk Assessment<br/>Sulfides<br/>Sulfoxides--analysis<br/>Turkey